Altay Therapeutics
Vivian Q. is a seasoned professional with extensive experience in the biotechnology and sustainability sectors. Currently serving as CXO at a stealth startup backed by leading renewable technology VCs, Vivian successfully raised an $8M angel round. As a Venture Fellow at SOSV, Vivian scouts investment opportunities for IndieBio SF’s accelerator. Additional roles include Venture Advisor for BioLumen Inc., Investor at Altay Therapeutics, and Chief Product Officer at Tidal Vision, focusing on biopolymer characterization. Previous positions include CEO and Founder of ViaeX Technologies Inc., an AI Application Consultant for NYSE, and participation in IndieBio's Cohort #4. Vivian holds a Master's degree in Material Science Engineering from the University of California, Berkeley, an Oxford Blockchain Strategy Programme certification, and a Bachelor's degree in Nanotechnology Engineering from UC San Diego.
This person is not in the org chart
This person is not in any teams
Altay Therapeutics
Altay Therapeutics uses a unique platform and drug development approach, Altay develops novel small molecule drugs targeting disease-causing transcription factors to treat chronic illnesses and cancers.